+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc. - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1588 Pages
  • Global
From
Hormone Replacement Therapy Market Report and Forecast 2023-2031 - Product Thumbnail Image

Hormone Replacement Therapy Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
Estrogen Receptor Positive Breast Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Estrogen Receptor Positive Breast Cancer Treatment - Global Strategic Business Report

  • Report
  • May 2026
  • 286 Pages
  • Global
From
Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World - Product Thumbnail Image

Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World

  • Report
  • November 2023
  • 63 Pages
  • Global
Anti-Allergy Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Allergy Drugs - Global Strategic Business Report

  • Report
  • May 2026
  • 168 Pages
  • Global
From
Personalized Medicine Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Personalized Medicine Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Age-related Macular Degeneration (AMD) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Age-related Macular Degeneration (AMD) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • June 2022
  • 320 Pages
  • Global
From
Rybrevant Bispecific Antibody Patent, Sales & Clinical Trials Outlook 2028 - Product Thumbnail Image

Rybrevant Bispecific Antibody Patent, Sales & Clinical Trials Outlook 2028

  • Report
  • October 2021
  • 78 Pages
  • Global
From
Radiation Therapy Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Radiation Therapy Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 107 Pages
  • Global
From
Biobetters - Global Strategic Business Report - Product Thumbnail Image

Biobetters - Global Strategic Business Report

  • Report
  • May 2026
  • 488 Pages
  • Global
From
Head and Neck Cancer (HNC) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Head and Neck Cancer (HNC) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • September 2022
  • 239 Pages
  • Global
From
Acute ischemic stroke (AIS) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Acute ischemic stroke (AIS) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 224 Pages
  • Global
From
Non-Small Cell Lung Cancer (NSCLC) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Non-Small Cell Lung Cancer (NSCLC) Therapeutics - Global Strategic Business Report

  • Report
  • May 2026
  • 271 Pages
  • Global
From
Influenza Medications Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Influenza Medications Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 115 Pages
  • Global
From
Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 2271 Pages
  • Global
From
AI Opportunities in Personalised Medicine - Product Thumbnail Image

AI Opportunities in Personalised Medicine

  • Report
  • March 2023
  • Global
From
DNA Repair Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

DNA Repair Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2024
  • 88 Pages
  • Global
From
Recombinant DNA Technology Market Analysis & Forecast to 2023-2033: Market By Product; By End User; and By Region - Product Thumbnail Image

Recombinant DNA Technology Market Analysis & Forecast to 2023-2033: Market By Product; By End User; and By Region

  • Report
  • July 2023
  • 145 Pages
  • Global
From
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 1814 Pages
  • Global
From
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1560 Pages
  • Global
From
Loading Indicator